Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 32,523 | 46,134 | 37,466 | 31,626 | 53,102 |
| Receivables | 63,426 | 63,745 | 67,199 | 69,013 | 61,556 |
| Other current assets | 20,154 | 19,959 | 31,129 | 24,449 | 21,108 |
| TOTAL | $125,701 | $135,153 | $137,977 | $127,465 | $137,968 |
| Non-Current Assets | |||||
| PPE Net | 1,832,800 | 1,807,560 | 1,787,041 | 1,796,552 | 1,751,966 |
| Investments And Advances | 77,036 | 80,582 | 69,705 | 78,066 | 84,097 |
| Intangibles | 24,816 | 25,485 | 26,032 | 26,342 | 13,814 |
| Other Non-Current Assets | 7,957 | 7,154 | 6,447 | 6,702 | 6,957 |
| TOTAL | $1,942,609 | $1,920,781 | $1,889,225 | $1,907,662 | $1,856,834 |
| Total Assets | $2,068,310 | $2,055,934 | $2,027,202 | $2,035,127 | $1,994,802 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 85,204 | 95,527 | 99,751 | 89,159 | 114,533 |
| Accounts payable and accrued liabilities | 67,475 | 46,088 | 43,441 | 42,104 | 34,007 |
| Accrued Expenses | 11,529 | 11,778 | 12,623 | 10,135 | 5,205 |
| TOTAL | $172,449 | $164,006 | $168,826 | $153,483 | $167,129 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,377,931 | 1,380,499 | 1,343,276 | 1,360,574 | 1,313,548 |
| Deferred Revenues | 8,241 | 10,613 | 13,011 | 12,085 | 13,384 |
| Other Non-Current Liabilities | 1,710 | 2,121 | 3,500 | 3,497 | 1,966 |
| TOTAL | $1,431,042 | $1,434,424 | $1,399,357 | $1,415,701 | $1,363,852 |
| Total Liabilities | $1,603,491 | $1,598,430 | $1,568,183 | $1,569,184 | $1,530,981 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 19,254 | 19,057 | 19,057 | 19,257 | 19,429 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | 330,852 | 324,576 | 325,243 | 330,658 | 326,901 |
| Other shareholders' equity | -7,881 | -8,132 | -6,875 | -7,012 | -6,043 |
| TOTAL | $464,819 | $457,504 | $459,019 | $465,943 | $463,821 |
| Total Liabilities And Equity | $2,068,310 | $2,055,934 | $2,027,202 | $2,035,127 | $1,994,802 |